BioPlus Acquisition Corp.

closedU=S+W/2W=S@11.50
BIOSSEC EDGARCIK: 0001856653|BioPlus Sponsor LLC

Capital Structure & Economics

Trust Size$183,600,000
Unit Price$10.00
Warrant Coverage1/2
Sponsor Promote20%

Implied Equity Architecture

Capital Allocation Baseline

Trust (100.0%)

Implied Dilution Drag

50% Warrant Inclusion
Public Trust Allocation$183,600,000
Sponsor At-Risk CapitalN/A
Total Underwriting DiscountN/A
Trust Per Unit (Implied)$10.00
Sponsor Promote Allocation20%
Deal Lifecycle
IPO PricedJul 20, 2021
SearchingTarget Pending
Maturation Wall
Jun 7, 2023

Announced Target / M&A

  • Target CompanyAvertix Medical
  • Announced Deal Size$132,000,000

Board & Officers

  • Ross Haghighat(3)
    CEO
  • Alex Vieux(2)Officer
  • Steven Fletcher(2)Officer
  • Jonathan RigbyDirector
  • Ronald EastmanDirector
  • Shawn CrossDirector
  • Louis G. Lange, M.D., Ph.D.Director
  • Stephen Sherwin, M.D.Director
  • Glen GiovannettiDirector
  • Alan C. MendelsonDirector
  • J. Leighton Read, M.D.Director

Syndicate & Advisors

Interactive Deal Modeling

Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.

Dilution Cash Friction